- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/20 - Interleukins
Patent holdings for IPC class A61K 38/20
Total number of patents in this class: 4816
10-year publication summary
|
231
|
232
|
279
|
373
|
352
|
426
|
399
|
429
|
386
|
250
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Iovance Biotherapeutics, Inc. | 340 |
92 |
| The Regents of the University of California | 20035 |
57 |
| Massachusetts Institute of Technology | 10093 |
56 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3178 |
50 |
| Altor BioScience, LLC | 76 |
47 |
| The Board of Trustees of the Leland Stanford Junior University | 6447 |
46 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3364 |
42 |
| Novartis AG | 10726 |
39 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2866 |
39 |
| Immunitybio, Inc. | 390 |
38 |
| Memorial Sloan-Kettering Cancer Center | 1940 |
36 |
| Genentech, Inc. | 3988 |
34 |
| Nektar Therapeutics | 439 |
33 |
| Bristol-myers Squibb Company | 4867 |
32 |
| The Trustees of the University of Pennsylvania | 4335 |
32 |
| Genexine, Inc. | 109 |
31 |
| Regeneron Pharmaceuticals, Inc. | 4312 |
31 |
| Xencor, Inc. | 396 |
31 |
| Dana-Farber Cancer Institute, Inc. | 2577 |
29 |
| Philogen S.p.A. | 126 |
28 |
| Other owners | 3993 |